New combo therapy shows promise for Hard-to-Treat colorectal cancer

This study tests a new treatment approach for people with advanced colorectal cancer that has spread to the liver, lungs, or abdomen and cannot be removed with surgery. The treatment combines a short course of radiation with immunotherapy (tislelizumab), chemotherapy (CAPOX), and a targeted drug (bevacizumab). The goal is to see if this combination can shrink tumors and control the disease. The study involves 33 participants and is currently active but no longer recruiting.